and function consequently to their different structural composition, metabolic demands, and functional manifestations.
Currently, there is only limited information on the associations of changes in TBW and body composition over time with changes in LV geometry and function in the general population. Therefore, we aimed to investigate these associations based on data from the prospective population-based SHIP (Study of Health in Pomerania).
Methods
Please see the Data Supplement for a more detailed description.
Study Sample
The Study of Health in Pomerania SHIP was conducted in Northeastern Germany. The study design has previously been described in detail. 12 In brief, 7008 individuals were randomly selected from the population aged 20 to 79 years. After exclusion of migrated or deceased persons, 6265 subjects remained. Among them, 4308 participated in the baseline examination (SHIP-0) between 1997 and 2001 (response rate 68.8%) and 3300 in the 5-year follow-up examination (SHIP-1) that was conducted between 2002 and 2006 (follow-up response 83.6%).
At SHIP-0, echocardiography was restricted to 1955 individuals (1050 women; 53.7%) who were 44 years or older. At SHIP-1, echocardiographic examinations were performed in all study participants. There were 1366 participants with complete data from echocardiographic examinations for SHIP-0 and SHIP-1. Individuals with an LV ejection fraction <45% (n=89) and prevalent myocardial infarction (n=93) at SHIP-0 or -1 were excluded to avoid the effect of previous cardiac diseases. We also excluded participants with missing covariate values (n=23). The final analytic sample compromised 1189 (694 women; 58.4%) subjects, aged 44 to 86 years.
All study participants gave written informed consent. The study was approved by the ethics committee of the University of Greifswald and complies with the Declaration of Helsinki.
Body Variables
Anthropometric measurements included height and weight based on recommendations of the World Health Organization. Weight was measured to the nearest 0.1 kg in light clothing and without shoes using standard digital scales. Body mass index was calculated as weight (kg)/height2 (m 2 
Echocardiographic Examination
Two-dimensional, M-mode, and Doppler echocardiography were performed using the Vingmed CFM 800A system (GE Medical Systems, Waukesha) as described in detail elsewhere. 15 Measurements of LV end-diastolic diameter (LVEDD) and LV end-systolic diameter and septal and posterior wall thickness (SWT, PWT) were performed according to the guidelines of the American Society of Echocardiography. 16 LV mass (LVM) was calculated according to the formula: LVM (g)=0.8×{1.04×[(LV EDD+SWT+PWT) 3 −LVEDD 3 ]}+0.6 g as described by Reichek and Devereux 17 and Devereux et al. 18 LV end-diastolic and endsystolic volumes were determined using the Teichholz equations. LV wall thickness (WT), relative wall thickness (RWT), LV ejection fraction (LVEF), LV stroke volume (LVSV), LV cardiac output (LVCO), LV endocardial fractional shortening (LVEFS), and LV midwall fractional shortening (LVMFS) were calculated following the formulas below according to the guidelines of the American Society of Echocardiography. 16 Transmitral pulsed-wave Doppler, exclusively at the follow-up examination (SHIP-1), was used to record the early (E) and late (A) wave ventricular filling velocities and the isovolumic relaxation time (IVRT) of the left ventricle. The E/A ratio was calculated as the peak velocity of the early LV filling (E wave) divided by the peak velocity of the late LV filling (A wave). The IVRT was determined by measuring the time (ms) between the aortic valve closure and the initiation of mitral inflow. 19 Certification examinations for interobserver variations revealed an agreement of >90%.
15

Statistical Analysis
To characterize the study sample, data were reported as the median (25th and 75th percentile) for continuous variables and as percentages for categorical variables. Changes (value in SHIP-1 minus value in SHIP-0) in body composition measures were associated with changes in parameters of LV geometry and function by linear regression models adjusted for sex, time between the examination in SHIP-0 and in SHIP-1, baseline values of age and height 2.7 (not for LVMI), baseline and follow-up values of sedentarism, smoking status and use of antihypertensive medication, and the mean of the baseline and the follow-up value of the respective body composition variable. The adjusted model for FFM and FM included both parameters in the model. Fractional polynomials were tested for possible nonlinear relationships between exposure and outcome. To account for dropout to follow-up, inverse probability weights were applied assuming a missing at random mechanism. In addition, to account for different sampling probabilities of individuals into the study, we repeated all analyses under consideration of the survey design in a sensitivity analysis.
A 2-sided P value <0.05 was considered statistically significant. Statistical analyses were performed using Stata 14.1 (Stata Corporation, College Station, TX).
Results
The number of individuals that gained TBW during the 5-year follow-up interval between SHIP-0 and SHIP-1 was higher than the number of individuals with stable or decreased TBW (Table II in 
Associations Between Changes in Body Composition and Changes in LV Geometry Over 5 Years
In multivariable regression analyses, we observed statistically significant positive associations of the change in TBW with changes in LVM, LVMI, and LVEDD. A 1-kg increase/ decrease in TBW was associated with an average increase/ decrease of 0.89 g in LVM, 0.24 g/m 2.7 in LVMI, and a 0.10-mm increase/decrease in LVEDD. There were no associations between changes in TBW and changes in WT and RWT (Figure 1 ; Table III in the Data Supplement).
Interestingly, we observed different patterns of association for the change in FM and FFM with changes in LV geometry. The change in FM was positively associated with changes in LVM, LVMI, WT, and RWT. These associations were markedly stronger than the ones observed for the change in TBW. A 1-kg increase/ decrease in FM was associated with an increase/decrease of 1.84 g in LVM, 0.45 g/m 2.7 in LVMI, 0.10 mm in WT, and 0.004 in RWT. There were no associations between changes of FM and changes of LVEDD (Figure 1 ; Table III in the Data Supplement).
Besides that, although the change in FFM was positively associated with changes in LVEDD, it was inversely associated with changes in WT and RWT. These associations were markedly stronger than the ones observed with the change in both TBW and FM. A 1-kg increase/decrease in FFM was associated with an increase/decrease of 0.56 mm in LVEDD Table III in the Data Supplement) .
The associations between the change in TBW, FFM, and FM and the change in LVM were not modified by sex or any of the other cofounders (all P values for interaction >0.1). In sensitivity analyses, the supplementary adjustment for the baseline LVM (Table IV in 
Associations Between Changes in Body Composition and Changes in LV Function Over 5 Years
We observed a positive association between change in TBW and the absolute change in LVCO. Specifically, an increase/ decrease of 1 kg in TBW was associated with an average increase/decrease of 0.03 L/min in LVCO. In contrast, the change of TBW was not associated with any of the other indicators of LV systolic and diastolic function (LVEF, LVSV, LVEFS, LVMFS, E/A ratio, and IVRT; Figure 2 ; Table VII in the Data Supplement).
The changes in FFM and FM had contrary effects on almost all functional LV parameters. The change in FFM was positively associated with changes in LVSV, LVCO, and LVMFS and with the follow-up values for E/A ratio and IVRT ( Figure 2 ; Table VII in the Data Supplement). In contrast, the change in FM was inversely associated with changes in LVSV, LVEFS, and LVMFS and with the follow-up value for E/A ratio. The increase/decrease of 1 kg in FFM was associated with an average increase/decrease of 3.62 mL in LVSV, 0.20 L/min in LVCO, and 0.63% in LVMFS and with higher/lower follow-up values of 0.03 in E/A ratio and 2.27 ms in IVRT. There were no associations with changes in LVEF and LVEFS (Figure 2 ; Table VII in the Data Supplement). However, the increase/decrease of 1 kg in FM was associated with an average decrease/increase of 0.80 mL in LVSV, 0.33% in LVEFS, and 0.22% in LVMFS and lower/higher follow-up value of 0.01 in E/A ratio. There was a weak inverse association between the change in FM and the change in LVEF, with a decrease/ increase of 0.004%, per 1-kg increase/decrease in FM, and no association with changes of LVCO and with follow-up values for IVRT (Figure 2 ; Table VII in the Data Supplement).
Discussion
Although increases in TBW and FM were associated with increases in LVM, an increase in FFM had no association with changes in LVM. Moreover, increases in TBW and FFM were associated with an eccentric remodeling in contrast to a concentric remodeling that was related to an increase in FM. Finally, although an increase in TBW was associated with higher cardiac output and an increase in FFM with better systolic and diastolic function, the increase in FM had the opposing effect.
On the other hand, as far as we know, this is the first large population-based cohort of adults to show beneficial effects of weight loss on LV geometry. The decrease in TBW and FM were associated with a decrease in LVM, a reversion in the LV remodeling and a better systolic and diastolic function.
In the Context of the Published Literature
Associations Between Changes in Body Composition and Changes in LV Geometry Over 5 Years
Our findings showed that an increase in TBW or FM was associated with an increase in LVM. In line with these findings, previous observational studies showed that greater weight 10, 20, 21 and FM, 11, 22 or visceral adipose tissue, 23, 24 were associated with higher LVM. However, we did not find an association between changes in FFM and changes in LVM. In contrast, the Strong Heart Study, 25 a cross-sectional study of 3107 American Indians, concluded that FFM was strongly associated with LVM than FM or body mass index. Likewise, previous studies [26] [27] [28] in athletes showed that an increase in FFM was associated with an increase in LVM. Contrary to these previous findings, one recent cross-sectional analyses of a population-based study 24 with 1941 individuals demonstrated that higher appendicular skeletal muscle mass was associated with lower LVMI.
We think that no previous observational study investigated the association between weight loss and change in LVM. However, several studies analyzed the effects of interventional weight loss on LVM. A recent systematic review and meta-analysis (including 23 studies with 1022 morbidly obese patients submitted to bariatric surgery and followed up to 12 years) 29 and previous interventional weight loss studies (by diet 30, 31 or bariatric surgery 4, 29, [32] [33] [34] [35] ) have showed that a decrease in weight (usually a marked loss) was followed by a decrease in LVM. Two studies, one 33 with 83 and the second 36 with 34 morbidly obese, submitted to laparoscopy gastric procedures, demonstrated that a mean decrease of 19.8 kg and 42.5 kg in weight was associated with a mean decrease of 8.2 g and 39.4 g in LVM after 12 months. Our results were in line with these studies. Compared with the baseline examination, and considering the 5-year period of normal aging, a loss of at least 13 kg of TBW was necessary to develop a lower LVM in the follow-up examination.
Previous studies have advocated that an eccentric LV remodeling accompanied higher weight, 8, 37 whereas more recent studies demonstrated a concentric LV pattern to be associated with increased weight. 10, 20, 21 However, all previous studies had a cross-sectional design. In our longitudinal data, an increase in TBW was associated with an eccentric remodeling of the LV. Moreover, the association with eccentric remodeling, without change in LVM and LVMI, was even stronger for an increase in FFM. The Strong Heart Study 25 and the Multi-Ethnic Study of Atherosclerosis, both crosssectional studies, 11 also showed that a higher value of FFM was associated with an eccentric remodeling. However, our analyses revealed that an increase in FM had the contrary effect, with a resulting LV concentric remodeling, which is in agreement with previous studies considering FM 11, 22 or visceral adipose tissue. 23 Changes in TBW, FFM, and FM With LVM Our study showed that an increase in TBW was associated with an increase in LVCO, but not with LVEF or other functional parameters. This is in line with previous studies on parameters of systolic LV function, such as LVEF, 38, 39 LVCO, 8 and LVMFS. 40 Moreover, previous cross-sectional studies showed that obesity was also associated with changes in diastolic LV parameters, such as an increase in IVRT 41 and a decrease in E/A ratio. 42, 43 The data about effects of FM and FFM on LV function are sparse. Previous studies demonstrated that an increase in FFM was not associated with LVEF, 28 LVEFS, 27 and LVMFS and E/A ratio. 26 In contrast, one study 24 found higher appendicular skeletal muscle mass to be associated with higher values of early diastolic velocity (Ea wave) and lower E/Ea ratio, determined by tissue Doppler imaging, suggesting a better diastolic function.
Our results showed that an increase in FM was associated with a decrease in LVEF, LVSV, LVEFS, and LVMFS and in the follow-up examination by lower values for E/A ratio. This is partly in concordance with previous studies, which showed that an increase in FM was associated with a decrease in LVMFS (but without effect on LVEFS), 22 whereas an increase in visceral adipose tissue 23 and visceral area fat 24 was associated with a decrease in LVCO and with lower values of tissue Doppler, respectively.
Potential Mechanisms for the Observed Associations
Previous studies 11, 44, 45 considered that an increase in LVM, observed in obese individuals, might be the result of an increased circulating blood volume and cardiac output necessary to supply the increased demands of the adipose tissue, characterizing a state of chronic volume overload. 11, 45 More recently, it has been suggested that FFM is responsible for almost all the metabolic demands of the body and seems to be the most important factor for the increase in the cardiac output in obese individuals. 25, 45, 46 The necessary increase in the cardiac output, without substantial change in the heart rate, will be met mainly by an increase in the cardiac dimensions.
Large amounts of FM might lead to an increase in LVM by the release of numerous biomarkers and inflammatory cytokines. 11 Likewise, the hyperinsulinemia that usually follows the presence of increased FM might induce myocardial hypertrophy. 47 In addition, the deposition of fat tissue and the presence of excess fatty acid and triglycerides in the myocardium might lead to an increase in LVM and at the same time to an impairment of the myocardium contraction capacity, through myocyte cellular dysfunction and death. 45, 48, 49 Conversely, FFM might have a protective metabolic effect, cushioning the excess of the previous cited markers associated with FM shielding the heart from the lipotoxicity and the deposition of fat tissue. These contrary effects might, potentially, be demonstrated in our results by the opposite effects of FM and FFM on WT, RWT, and LVMFS.
The decrease in LVM observed in our analyses, after the decrease in TBW, might be explained by a reversal in the increased circulating blood volume and the release of deleterious biomarkers. Consequently, a reduction in TBW, with exercise training that might decrease FM and preserve FFM, might result in a potential supplementary beneficial effect on LV geometry and function. 50 
Study Limitations
Some limitations of our analyses should be mentioned. First, we used a formula, following height-weight model results from a previous BIA, rather than a direct measure of FFM and FM, which permitted just an estimated evaluation of these parameters. However, using data from the second follow-up of our study (SHIP-2; n=2271), we found a strong correlation between the measured (by BIA) and the calculated (by formula) values for FFM and FM (Figures I and II and Table I in the Data Supplement).
Moreover, this formula was already used in previous analyses using data from other population-based study. 11 Second, we were not able to separate FM in subcomponents (such as visceral and subcutaneous fat, liver and epicardial fat), which might have different effects on LV geometry and function. Third, we did not have data about a possible influence of frailty, heart failure, or other severe system illness that might have contributed to weight loss from baseline to first follow-up examination. Fourth, our study sample consisted of middle-aged whites, and it is unknown whether our findings are also applicable to other ethnicities and age groups. Finally, although we have incorporated several covariates in our multivariable regression models, we cannot exclude the possibility of residual confounding.
Notwithstanding these limitations, our analyses have also some significant strengths, including the population-based setting, the large number of individuals of both sexes, the robust and well-standardized data set, and the adjustment for confounding.
Conclusions
Our findings suggest a complex relationship between changes in body composition and LV geometry and function.
Our findings require validation in other independent samples, and the specific molecular mechanisms explaining these associations deserve further studies. 
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